Summary: During Fierce JPM Week 2022, Catalent’s President and COO Alessandro Maselli sat down and discussed how the pandemic changed the pharmaceutical landscape and how CDMOs…
Summary: In this webinar, experts provide an overview of the needs of different patient populations and examine the common challenges leading to non-compliance.
Summary: Catalent’s CEO John Chiminski and Endpoints News’ John Carroll have a virtual fireside chat discussing their predictions for what 2022 has in store for the biopharma industry.
Summary: During this webinar, biopharma R&D professionals will review strategies for moving successfully and efficiently from preclinical studies to first-in-human trials. They will call upon their own experiences to provide advice that will help others in the industry navigate this crucial transition.
Summary: In this webinar, experts provide an overview of the latest trends in manufacturing of oral solid dosage form and discuss key considerations of transitioning an early-stage project to late-stage as well as technology transfer.
